Temporomandibular dysfunction
Conditions
Interventions
This is a four-arm, double-blind, randomized controlled clinical trial. The experimental groups (124 women) are as follows: Fitzpatrick I and II + Photobiomodulation Therapy (31 women), Fitzpatrick II
E02.594.540
Sponsors
Universidade de São Paulo
Universidade de São Paulo
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 55 years; female gender; presence of reported pain in the facial region lasting at least three months; and presence of a diagnosis of myofascial pain according to the evaluation criteria of the revised version of the Diagnostic Criteria for Temporomandibular Disorders - DC/TMD (Axis I, categories Ia and Ib)
Exclusion criteria
Exclusion criteria: Women who are receiving any treatment for Temporomandibular Disorders or accumulate simultaneous interventions outside of this protocol; have a history of tumor, trauma or head and neck surgery; a previous diagnosis of fibromyalgia or other painful musculoskeletal syndromes; neurological and psychiatric disorders; use of anxiolytics, antidepressants and anticonvulsants; or who are pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction by Numerical Rating Pain Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Verification of Glutamate, Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), and Cortisol Levels. | — |
Countries
Brazil
Contacts
Public ContactCarlos Girasol
Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto da Universidade de São Paulo
Outcome results
None listed